Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.2K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.7K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.4K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Decoding preeclampsia: A fusion of multi-view machine learning and multi-omics to identify putative inflammation-related mechanisms.

Molecular therapy. Nucleic acids·2026
Same author

The PhNH10-PhDREB1C-PhPOD/Ph3GT module positively regulates cold stress tolerance by scavenging reactive oxygen species in Petunia.

Plant physiology·2026
Same author

Physiological and multi-omics analyses reveal distinct effects of green light and increased silicate supply on cellular fucoxanthin content and fucoxanthin titer in Thalassiosira weissflogii.

Bioresource technology·2026
Same author

The impact of mobile payment on rice farmers' purchasing behavior of new rice varieties: a case study of rice cultivation in Jiangxi Province.

Frontiers in nutrition·2026
Same author

Highly Dissymmetric and Multicolor Circularly Polarized Organic Hyperafterglow.

Angewandte Chemie (International ed. in English)·2026
Same author

A multi-objective optimization framework for planning electric vehicle charging infrastructure incorporating traffic demand, cost, and equity considerations.

Scientific reports·2026

Video Experimental Relacionado

Updated: Sep 10, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Aprendizaje de contraste de múltiples vistas para la predicción de eventos de interacción entre fármacos

Dongxu Li, Feifan Zhao, Yue Yang

    IEEE journal of biomedical and health informatics
    |August 20, 2025
    PubMed
    Resumen

    La predicción de las interacciones medicamentosas es crucial para la seguridad del paciente. Un nuevo marco de aprendizaje contrastante de múltiples vistas (MCL-DDI) identifica con precisión eventos complejos de DDI utilizando datos moleculares y de red.

    Más Videos Relacionados

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.3K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.0K

    Videos de Experimentos Relacionados

    Last Updated: Sep 10, 2025

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.8K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.3K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.0K

    Área de la Ciencia:

    • Farmacología y Química Computacional

    Sus antecedentes:

    • Las interacciones medicamentosas (IDM) presentan riesgos significativos que afectan a la eficacia del tratamiento y a la seguridad del paciente.
    • La predicción precisa de eventos DDI es vital para la medicina personalizada y el desarrollo de fármacos.

    Objetivo del estudio:

    • Introducir MCL-DDI, un nuevo marco de aprendizaje por contraste de múltiples vistas para mejorar la predicción de eventos DDI.
    • Aprovechar diversas representaciones de fármacos para mejorar la precisión en la identificación de las interacciones farmacológicas.

    Principales métodos:

    • Estructuras moleculares integradas y características de red para crear representaciones de fármacos de múltiples vistas.
    • Aprendizaje contrastante empleado para alinear y unificar representaciones a través de diferentes puntos de vista.
    • Validación del marco sobre conjuntos de datos de referencia para la predicción de eventos DDI.

    Principales resultados:

    • El MCL-DDI superó significativamente a los métodos de última generación existentes en cuanto a precisión predictiva.
    • Los estudios de caso demostraron la capacidad del modelo para identificar DDI clínicamente relevantes.
    • El marco mostró un rendimiento sólido en la distinción de patrones de interacción complejos.

    Conclusiones:

    • MCL-DDI proporciona un enfoque potente y preciso para la predicción de eventos DDI.
    • Este marco ofrece ideas prácticas para el desarrollo de fármacos y la evaluación de riesgos.
    • El estudio avanza el paradigma para garantizar intervenciones farmacológicas más seguras y efectivas.